Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-191457
Filing Date
2004-11-09
Accepted
2004-11-09 17:06:07
Documents
8
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2004 d10q.htm 10-Q 686680
2 ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION dex31.htm EX-3.1 5846
3 RESTATED SECOND AMENDMENT TO EMPLOYMENT AGREEMENT dex101.htm EX-10.1 7065
4 NONQUALIFIED STOCK OPTION AGREEMENT dex102.htm EX-10.2 19236
5 FORM OF STOCK OPTION AGREEMENT (NON-EMPLOYEE DIRECTOR) dex103.htm EX-10.3 13737
6 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 6384
7 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 6305
8 SECTION 906 CEO AND CFO CERTIFICATION dex32.htm EX-32 5764
  Complete submission text file 0001193125-04-191457.txt   753785
Mailing Address 4400 BISCAYNE BOULEVARD MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD MIAMI FL 33137 3055756000
IVAX CORP (Filer) CIK: 0000772197 (see all company filings)

EIN.: 161003559 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-09623 | Film No.: 041130437
SIC: 2834 Pharmaceutical Preparations